As shown in Figure 2C, a similar correlation was found between elevated GATA2 protein expression and malignant progression of prostate cancer, as shown for clinical prostate cancer samples with (i) increased lymph node involvement, (ii) following neo-adjuvant treatment and (iii) development of castration resistance. The gene discussed is GATA2; the disease is Familial prostate cancer.